Literature DB >> 10448421

Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease.

P Calabresi1, D Centonze, A Pisani, G Bernardi.   

Abstract

Differential sensitivity to glutamate has been proposed to contribute to the cell-type-specific vulnerability observed in neurological disorders affecting the striatum such as Huntington's disease (HD) and global ischemia. Under these pathological conditions striatal spiny neurons are selectively lost while large aspiny (LA) cholinergic interneurons are spared. We studied the electrophysiological effects of metabotropic glutamate receptor (mGluR) activation in striatal spiny neurons and LA interneurons in order to define the role of these receptors in the pathophysiology of the striatum. DCG-IV and L-SOP, agonists for group II and III mGluRs respectively, produced a presynaptic inhibitory effect on corticostriatal glutamatergic excitatory synaptic potentials in both spiny neurons and LA interneurons. Activation of group I mGluRs by the selective agonist 3,5-DHPG produced no detectable effects on membrane properties and glutamatergic synaptic transmission in spiny neurons while it caused a slow membrane depolarization in LA interneurons coupled to increased input resistance. In combined electrophysiological and microfluorometric recordings, 3,5-DHPG strongly enhanced membrane depolarizations and intracellular Ca2+ accumulation induced by NMDA applications in spiny neurons but not in LA interneurons. Activation of protein kinase C (PKC) by phorbol 12,13-diacetate mimicked this latter action of 3,5-DHPG while the facilitatory effect of 3,5-DHPG was prevented by calphostin C, an inhibitor of PKC. These data indicate that a positive interaction between NMDA receptors and group I mGluRs, via PKC activation, is differently expressed in these two neuronal subtypes. Our data also suggest that differential effects of the activation of group I mGluRs, but not of group II and III mGluRs, might partially account for the selective vulnerability to excitotoxic damage observed within the striatum.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10448421     DOI: 10.1006/exnr.1999.7092

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  25 in total

1.  Effects of mutant huntingtin on mGluR5-mediated dual signaling pathways: implications for therapeutic interventions.

Authors:  Shan-Shan Huang; Jun He; Dong-Ming Zhao; Xiao-Yuan Xu; Hui-Ping Tan; He Li
Journal:  Cell Mol Neurobiol       Date:  2010-07-20       Impact factor: 5.046

Review 2.  Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Faqi Li
Journal:  Curr Neurovasc Res       Date:  2005-12       Impact factor: 1.990

Review 3.  Cause or compensation?-Altered neuronal Ca2+ handling in Huntington's disease.

Authors:  James P Mackay; Wissam B Nassrallah; Lynn A Raymond
Journal:  CNS Neurosci Ther       Date:  2018-02-09       Impact factor: 5.243

4.  mGluRI targets microglial activation and selectively prevents neuronal cell engulfment through Akt and caspase dependent pathways.

Authors:  Zhao Zhong Chong; Jingqiong Kang; Faqi Li; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2005-07       Impact factor: 1.990

5.  Increased GAD expression in the striatum after transient cerebral ischemia.

Authors:  Yan Li; Glenn Dave Blanco; Zhigang Lei; Zao Cheng Xu
Journal:  Mol Cell Neurosci       Date:  2010-07-24       Impact factor: 4.314

6.  The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat.

Authors:  L Dawson; A Chadha; M Megalou; S Duty
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

7.  Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling.

Authors:  Akinori Nishi; Feng Liu; Seiichiro Matsuyama; Miho Hamada; Hideho Higashi; Angus C Nairn; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

8.  Metabotropic glutamate receptor 5 upregulates surface NMDA receptor expression in striatal neurons via CaMKII.

Authors:  Dao-Zhong Jin; Bing Xue; Li-Min Mao; John Q Wang
Journal:  Brain Res       Date:  2015-08-06       Impact factor: 3.252

9.  Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1.

Authors:  Tie-Shan Tang; Huiping Tu; Edmond Y W Chan; Anton Maximov; Zhengnan Wang; Cheryl L Wellington; Michael R Hayden; Ilya Bezprozvanny
Journal:  Neuron       Date:  2003-07-17       Impact factor: 17.173

Review 10.  Glutamate receptors and Parkinson's disease: opportunities for intervention.

Authors:  Michael J Marino; Ornella Valenti; P Jeffrey Conn
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.